HAE - HAEMONETICS CORP MASS
This page shows which of the focused investors we track hold HAE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2026 it was held by 1 manager with an aggregate reported value of $154.57M, which is 0.01% of the combined portfolio.
As of Q2 2026, 1 tracked institutional manager held HAE (HAEMONETICS CORP MASS) with an aggregate reported value of $154.57M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades HAE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2026
- Ticker
- HAE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Ariel Investments - Ariel Investments | 1.54% | New | 2,060,966 | $154.57M |
Loading holder history for HAE…